| Literature DB >> 7764474 |
Abstract
Significant progress has been made in our understanding of some of the important physiological and pharmacological barriers that limit immunoconjugate efficacy. Recent successes obtained employing immunotoxins in the treatment of leukemia and lymphoma in mouse models are suggesting ways of improving clinical strategies to treat these diseases in humans.Entities:
Mesh：
Substances：
Year: 1993 PMID： 7764474 DOI： 10.1016/0958-1669(93)90059-6
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN： 0958-1669 Impact factor: 9.740